Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 17,50117,520 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Positive Affect, Future Thinking, and Planning: Testing Brief Intervention Components to Optimize a Novel Intervention to Promote Physical Activity
NATIONAL CANCER INSTITUTE Southern Methodist University United States 2021 – 2023

Project Summary Insufficient levels of regular physical activity (< 150 minutes/week of moderate-to-vigorous physical activity [MVPA]) are associated with various health risks,...

$2.35M
USD
Completed NON-SBIR/STTR RPGS
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

ABSTRACT Despite recent progress in immunotherapy (checkpoint blockade and adoptive T cell transfer), most patients with solid tumors still do not respond or subsequently develop a...

$6.34M
USD
Completed SBIR-STTR RPGS
Flow Responsive Embolic Agent for the Complete Devascularization of Meningiomas
NATIONAL CANCER INSTITUTE Arsenal Medical, Inc United States 2021 – 2023

PROJECT SUMMARY Significance: Pre-operative embolization (POE) of meningiomas is an established neuroendovascular procedure performed to reduce the extensive amount of blood loss t...

$7.91M
USD
Completed NON SBIR/STTR CONTRACTS
TO PROVIDE THE DENOMINATOR DATA REQUIRED FOR THE NCI TO RELEASE CANCER RATES BY SINGLE RACE AND ETHNICITY AMONG IMMIGRANTS AND EASY-TO-ACCESS ACS SAMP
NATIONAL CANCER INSTITUTE University of Minnesota United States 2021 – 2022

The study of racial disparities in cancer incidence and mortality rates among immigrants requires population data by immigration status and single-race categories.The American Comm...

$375.6K
USD
Completed NON-SBIR/STTR RPGS
Clinical & Mechanistic underpinnings to reducing PAX:FOXO1 for alveolar rhabdomyosarcoma
NATIONAL CANCER INSTITUTE Children'S Cancer Therapy Develop/Inst United States 2021 – 2026

SUMMARY The childhood muscle cancer alveolar rhabdomyosarcoma (ARMS) is generally not survivable when metastatic. However, ARMS does usually respond clinically to chemotherapy init...

$2.98M
USD
Completed NON-SBIR/STTR RPGS
Cellular interactions between TGF-beta pathway members and epignetic regulators in liver and gastrointestinal cancers
NATIONAL CANCER INSTITUTE Feinstein Institute for Medical Research United States 2021 – 2024

Contact PD/PI: Mishra, Lopa Project-001 (001) ABSTRACT Transforming Growth Factor-Beta (TGF-β) is a potent regulator of stem cell differentiation, epigenetic alterations, inflammat...

$3.58M
USD
Completed NON-SBIR/STTR RPGS
Clinical & Mechanistic underpinnings to reducing PAX:FOXO1 for alveolar rhabdomyosarcoma
NATIONAL CANCER INSTITUTE Children'S Cancer Therapy Develop/Inst United States 2021 – 2026

SUMMARY The childhood muscle cancer alveolar rhabdomyosarcoma (ARMS) is generally not survivable when metastatic. However, ARMS does usually respond clinically to chemotherapy init...

$2.98M
USD
Completed NON-SBIR/STTR RPGS
Clinical & Mechanistic underpinnings to reducing PAX:FOXO1 for alveolar rhabdomyosarcoma
NATIONAL CANCER INSTITUTE Children'S Cancer Therapy Develop/Inst United States 2021 – 2026

SUMMARY The childhood muscle cancer alveolar rhabdomyosarcoma (ARMS) is generally not survivable when metastatic. However, ARMS does usually respond clinically to chemotherapy init...

$2.89M
USD
Completed NON-SBIR/STTR RPGS
Clinical & Mechanistic underpinnings to reducing PAX:FOXO1 for alveolar rhabdomyosarcoma
NATIONAL CANCER INSTITUTE Children'S Cancer Therapy Develop/Inst United States 2021 – 2026

SUMMARY The childhood muscle cancer alveolar rhabdomyosarcoma (ARMS) is generally not survivable when metastatic. However, ARMS does usually respond clinically to chemotherapy init...

$3.04M
USD
Completed NON-SBIR/STTR RPGS
Adaptive randomized designs for cancer clinical trials by using integer algorithms and exact Monte Carlo methods
NATIONAL CANCER INSTITUTE University of Florida United States 2021 – 2024

Project Summary/Abstract Current phase II clinical trial designs for cancer studies are generally not flexible and effective enough to reduce sample size and costs. Unlike tradition...

$762.5K
USD
Completed NON-SBIR/STTR RPGS
Cellular interactions between TGF-beta pathway members and epignetic regulators in liver and gastrointestinal cancers
NATIONAL CANCER INSTITUTE Feinstein Institute for Medical Research United States 2021 – 2023

Contact PD/PI: Mishra, Lopa Project-001 (001) ABSTRACT Transforming Growth Factor-Beta (TGF-?) is a potent regulator of stem cell differentiation, epigenetic alterations, inflammat...

$3.65M
USD
Completed NON-SBIR/STTR RPGS
Adaptive randomized designs for cancer clinical trials by using integer algorithms and exact Monte Carlo methods
NATIONAL CANCER INSTITUTE University of Florida United States 2021 – 2023

Project Summary/Abstract Current phase II clinical trial designs for cancer studies are generally not ?exible and effective enough to reduce sample size and costs.Unlike traditiona...

$762.5K
USD
Completed NON-SBIR/STTR RPGS
Novel Bisphosphonate PET Probes for Myeloma Bone Disease
NATIONAL CANCER INSTITUTE University of Southern California United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT Multiple myeloma (MM), a malignancy of mature plasma cells, is the second most common hematologic malignancy. Myeloma bone disease (MBD) is a devastating c...

$1.93M
USD
Completed NON-SBIR/STTR RPGS
Epigenetic contribution to the excess risk of MGUS in African Americans
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2021 – 2026

ABSTRACT The goal of this investigation is to characterize the influence of the DNA methylome central to the increased risk of Monoclonal Gammopathy of Undetermined Significance (M...

$6.16M
USD
Completed NON-SBIR/STTR RPGS
Epigenetic contribution to the excess risk of MGUS in African Americans
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2021 – 2026

ABSTRACT The goal of this investigation is to characterize the influence of the DNA methylome central to the increased risk of Monoclonal Gammopathy of Undetermined Significance (M...

$5.97M
USD
Completed NON-SBIR/STTR RPGS
Novel Bisphosphonate PET Probes for Myeloma Bone Disease
NATIONAL CANCER INSTITUTE University of Southern California United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Multiple myeloma (MM), a malignancy of mature plasma cells, is the second most common hematologic malignancy. Myeloma bone disease (MBD) is a devastating c...

$1.89M
USD
Completed NON-SBIR/STTR RPGS
Epigenetic contribution to the excess risk of MGUS in African Americans
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2021 – 2026

ABSTRACT The goal of this investigation is to characterize the influence of the DNA methylome central to the increased risk of Monoclonal Gammopathy of Undetermined Significance (M...

$6.04M
USD
Completed NON-SBIR/STTR RPGS
Novel Bisphosphonate PET Probes for Myeloma Bone Disease
NATIONAL CANCER INSTITUTE University of Southern California United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT Multiple myeloma (MM), a malignancy of mature plasma cells, is the second most common hematologic malignancy. Myeloma bone disease (MBD) is a devastating c...

$2.27M
USD
Completed NON-SBIR/STTR RPGS
Epigenetic contribution to the excess risk of MGUS in African Americans
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2021 – 2026

ABSTRACT The goal of this investigation is to characterize the influence of the DNA methylome central to the increased risk of Monoclonal Gammopathy of Undetermined Significance (M...

$5.85M
USD
Completed OTHER RESEARCH-RELATED
Tumor Intrinsic Regulation of Immune Evasion Pathways in Breast Cancer
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2021 – 2025

Project Summary/Abstract: The incidence rate of cutaneous melanoma has doubled since 1973, and is increasing more rapidly than any other cancer.FDA-approved targeted inhibitors and...

$869.7K
USD